Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation

BACKGROUND: The RESTORE study, a multi-national randomized, placebo-controlled study, showed that erdosteine – a muco-active antioxidant that modulates bacterial adhesiveness – reduced the rate and duration of exacerbations in moderate and severe COPD with a history of exacerbations. How much benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Calverley, Peter MA, Page, Clive, Dal Negro, Roberto W, Fontana, Giovanni, Cazzola, Mario, Cicero, Arrigo F, Pozzi, Edoardo, Wedzicha, Jadwiga A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896911/
https://www.ncbi.nlm.nih.gov/pubmed/31819405
http://dx.doi.org/10.2147/COPD.S221852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896911/
https://www.ncbi.nlm.nih.gov/pubmed/31819405
http://dx.doi.org/10.2147/COPD.S221852

Ejemplares similares